Moore LE. Thyroid disease in pregnancy: A review of diagnosis, complications and management. World J Obstet Gynecol 2016; 5(1): 66-72 [DOI: 10.5317/wjog.v5.i1.66]
Corresponding Author of This Article
Lisa E Moore, MD, MS, FACOG, ARDMS, Department of Obstetrics and Gynecology, Texas Tech Health Sciences Center, 4801 Alberta Ave., El Paso, TX 79905, United States. lisa.e.moore@ttuhsc.edu
Research Domain of This Article
Obstetrics & Gynecology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
220 children were evaluated at 10 mo of age. Maternal TSH, FT4 and TPO antibodies were measured at 12 and 32 wk of pregnancy
Children of women with FT4 levels less than the 5th and 10th centiles at 12 wk had lower scores on the Bayley Psychomotor Development Index at 10 mo. No differences were found at 32 wk
FT4 < 10% ile at 12 wk is a risk factor for impaired psychomotor development in offspring
Women with normal TSH and FT4 < 5th and 10th centile. Expressive vocabulary of children was evaluated by mother at 18 and 30 mo
Maternal TSH not related to outcome. Both mild and severe low FT4 associated with higher risk of expressive language delay at all ages. Severe had higher risk of nonverbal cognitive delay
Maternal low FT4 is a risk factor for early childhood cognitive delay
Women in screening group were tested and treated Women in the control group had stored samples which were tested after delivery and received no treatment during pregnancy
No difference in cognitive function between the two groups at 3 yr of age
Screening and treatment for hypothyroidism did not improve neurodevelopmental outcomes in the offspring